Details for 2017704548

Up to date per 01.04.2026

Actions

Title / Product Name

VERWENDUNG VON INHIBITOREN DER AKTIVITÄT ODER FUNKTION VON PI3K ZUR BEHANDLUNG DES PRIMÄREN SJÖGREN-SYNDROMS

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2017704548

EP Publication Number

3413894

E-Number

1242298

Language

PCT Number

IB17050743

Publication Date

19.12.2018 A

11.03.2020 B1

Registration Date

11.03.2020

AT Publication Date

15.03.2020

Application Date

10.02.2017

Registration Number

Priorities

10.02.2016

16155123

29.08.2016

16186188

IPC

A61K 31/519 20060101AFI20170803BHEP

Maximum Duration of Protection

10.02.2037

Owner

Novartis AGLichtstrasse 35 4056 BaselCH

Representative

Häupl & Ellmeyer KG, PatentanwaltskanzleiMariahilfer Straße 50 (Eingang Kirchengasse 1)1070 WienAT

Inventor

BIETH, BrunoNovartis Pharma AG Novartis Institutes for Biomed. Research Postfach 4002 BaselCH

BURKHART, ChristophNovartis Pharma AG Novartis Institutes for Biomed. Research Postfach 4002 BaselCH

CHRIST, AndreasNovartis Pharma AG Novartis Institutes for Biomed. Research Postfach 4002 BaselCH

DE BUCK, StefanNovartis Pharma AG Novartis Institutes for Biomed. Research Postfach 4002 BaselCH

KALIS, ChristophNovartis Pharma AG Novartis Institutes for Biomed. Research Postfach 4002 BaselCH

LINDGREN, SamNovartis Pharma AG Novartis Institutes for Biomed. Research Postfach 4002 BaselCH

Information about Fees